Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
In Situ Hybridization Market Size Forecast: How Big Could The Market Get By 2030?
The market for in situ hybridization has experienced swift expansion over recent years. Its trajectory indicates an increase from $1.81 billion in 2025 to $2.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. This historical growth is traceable to several factors, including the widening scope of molecular pathology research, a heightened demand for cancer diagnostics, the proliferation of cytogenetic testing applications, the presence of sophisticated laboratory infrastructure, and the growing uptake of FISH techniques.
The in situ hybridization market is projected to experience swift expansion in the coming years. This market is forecast to reach $3.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This anticipated growth is driven by several factors, including the escalating demand for personalized medicine diagnostics, the increasing incorporation of AI-powered image analysis, the widening scope of companion diagnostics applications, rising investments in genomic research, and the expanded application of in situ hybridization in detecting infectious diseases. Key trends anticipated during this period encompass the greater adoption of fluorescence-based hybridization methods, a heightened need for precision in molecular diagnostics, the increasing deployment of automated imaging and analysis platforms, the broadening of cancer diagnostic uses, and improved integration of digital pathology solutions.
Get A Free Sample Report With In-Depth Market Insights:
In Situ Hybridization Market Expansion Drivers: What’s Shaping Future Growth?
The projected expansion of the in-situ hybridization market is anticipated to be driven by a rise in infectious diseases. These illnesses are characterized by their transmission between people through contaminated food and drinks, or via pathogens including viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) utilizes labeled nucleic acid sequences (probes) specific to an infectious organism to identify complementary nucleic acid sequences in tissue. This process, therefore, sees its market growth boosted by the rise in infectious diseases. As an illustration, data from the US government agency, the Centers for Disease Control and Prevention, revealed in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increment of 1,295 cases. Consequently, the growing prevalence of infectious diseases is propelling the expansion of the in-situ hybridization market.
In Situ Hybridization Market Segment Landscape And Growth Outlook
The in situ hybridization market covered in this report is segmented –
1) By Product: Analytical Instruments, Kits and Reagents, Software and Services
2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)
3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases
5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes
Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems
2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents
3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services
In Situ Hybridization Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the in situ hybridization market are concentrating on innovative product solutions, such as HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization), to enhance their profitability within the market. Hybridization Chain Reaction RNA Chromogenic in situ Hybridization is defined as a technique that facilitates the visualization of RNA molecules in cells and tissues with high resolution and sensitivity. For example, in February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, introduced HCR RNA-CISH to improve automated chromogenic in situ hybridization (ISH) workflows that rely on RNAscope. The HCR RNA-CISH kits offer superior performance compared to any existing chromogenic in situ hybridization approach, even with double the turnaround time and half the cost. Furthermore, it features native support for IHC (Immunohistochemistry) codetection and full compatibility with all major automation platforms.
In Situ Hybridization Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S
View The Full In Situ Hybridization Market Report:
In Situ Hybridization Market Geographic Spread And Regional Opportunities
North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model